Xalacom comprises a combination of two active substances, latanoprost and timolol. Latanoprost, a prostaglandin analogue, plays a vital role in modulating aqueous humor outflow. Its structural formula, C26H40O5, displays a unique arrangement conducive to biological activity. Timolol, a non-selective beta-adrenergic receptor antagonist, features a distinct C13H24N4O3S structure. This component inhibits ocular hypertension by decreasing aqueous humor production. The amalgamation of these elements results in a potent pharmaceutical product targeting intraocular pressure.
The formulation integrates latanoprost 50 micrograms/ml and timolol 5 mg/ml. This balanced combination ensures effective management of glaucoma-related conditions. The molecular synergy enhances therapeutic efficacy, providing substantial relief from pressure-induced ocular damage. Such a detailed composition serves a critical role in understanding Xalacom’s function and impact.
Xalacom primarily addresses ocular hypertension and open-angle glaucoma. By harnessing the power of both latanoprost and timolol, this ophthalmic solution significantly reduces intraocular pressure. Regular administration of Xalacom, one drop in the affected eye(s) once daily, preferably in the evening, proves beneficial in managing these chronic eye conditions. The synergy between the two active ingredients allows for enhanced fluid drainage from the eye, preventing vision loss and optic nerve damage.
Its targeted action makes Xalacom a preferred option for patients unresponsive to monotherapy. By stabilizing intraocular pressure, this medication offers patients a lifeline in preserving visual health. Patients must adhere to their prescribed dosage regimen for optimal outcomes. Proper application technique is crucial to maximize the therapeutic potential of this solution.
Individuals with hypersensitivity to latanoprost, timolol, or any excipients in the formulation should avoid Xalacom. Its use is contraindicated in patients with severe asthma, chronic obstructive pulmonary disease, or heart block. Cardiac dysfunction may exacerbate under the influence of timolol.
Patients with a history of certain respiratory conditions should exercise caution. Lactating mothers and pregnant women are advised to consult healthcare providers before use. A comprehensive medical history assessment is essential to identify potential contraindications and avert adverse reactions.
If a dose is missed, it should be administered as soon as remembered. However, if the next scheduled dose is imminent, the missed dose should be skipped. Doubling up doses to compensate for missed ones may lead to complications.
Establishing a consistent dosing schedule minimizes the risk of missing doses. Patients are encouraged to integrate this medication into their daily routine. Consistency in administration enhances the therapeutic effects of Xalacom.
Overdosage of Xalacom may lead to significant systemic side effects. Symptoms can range from dizziness and fatigue to respiratory difficulties. These adverse effects stem primarily from the timolol component.
In the event of overdose, immediate medical attention is necessary. Monitoring vital signs and supportive care may be required. Healthcare providers may need to employ specific interventions to manage overdose cases effectively.
Xalacom is available through several online pharmaceutical platforms. It’s crucial to choose reputable pharmacies to ensure medication authenticity. Opting for verified sources minimizes the risk of counterfeit products.
Patients should look for licensed online pharmacies with positive reviews. Comparisons of pricing and availability can guide purchasing decisions. Consider the delivery options and customer service offered by online suppliers.
| Formulation | Strength |
|---|---|
| Latanoprost | 50 micrograms/ml |
| Timolol | 5 mg/ml |
In conclusion, Xalacom emerges as a formidable ally in ocular health management. Its dual-action formula provides significant relief from elevated intraocular pressure. Proper adherence to dosing regimens and medical guidance ensures optimal benefits. Careful consideration of contraindications and overdose risks is paramount for patient safety.
DHANVANTRI BIOMEDICAL PRIVATE LIMITED – NO 425/2, AVC SARANYA CAMPUS, MAAVUTHAMPATHI VILLAGE, NAVAKKARAI, COIMBATORE – 641105
Developed by ITEdge Solutions
